300841 康华生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)5.43911.45315.45520.81735.717
总资产报酬率 ROA (%)4.7489.68012.85817.77632.115
投入资产回报率 ROIC (%)5.17410.83214.66520.24735.622

边际利润分析
销售毛利率 (%)92.28994.20393.45393.56293.520
营业利润率 (%)26.39132.63436.55547.38370.855
息税前利润/营业总收入 (%)26.00132.01935.88546.50769.205
净利润/营业总收入 (%)22.51227.84132.28241.33964.179

收益指标分析
经营活动净收益/利润总额(%)102.388119.201107.69097.33970.491
价值变动净收益/利润总额(%)2.214-12.598-5.4448.32229.924
营业外收支净额/利润总额(%)-0.021-0.056-0.456-0.250-0.020

偿债能力分析
流动比率 (X)5.8524.3933.8973.5075.731
速动比率 (X)5.4954.0813.6433.2565.420
资产负债率 (%)10.94214.40316.51617.12211.522
带息债务/全部投入资本 (%)3.8725.0135.0864.4730.022
股东权益/带息债务 (%)2,470.3321,887.3911,859.1922,130.120449,460.361
股东权益/负债合计 (%)813.946594.323505.461484.054767.900
利息保障倍数 (X)-67.702-53.596-71.230-61.344-42.318

营运能力分析
应收账款周转天数 (天)420.146340.596307.828264.297165.712
存货周转天数 (天)675.766759.877570.290500.834334.013